Viewing Study NCT05002868


Ignite Creation Date: 2025-12-24 @ 5:51 PM
Ignite Modification Date: 2025-12-31 @ 2:18 AM
Study NCT ID: NCT05002868
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2021-08-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Pharmacokinetics and Anti-tumor Activity of RP12146, in Patients With Solid Tumors
Sponsor: Rhizen Pharmaceuticals SA
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-10-05
Start Date Type: ACTUAL
Primary Completion Date: 2024-04-25
Primary Completion Date Type: ACTUAL
Completion Date: 2024-04-25
Completion Date Type: ACTUAL
First Submit Date: 2021-08-05
First Submit QC Date: None
Study First Post Date: 2021-08-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-11
Last Update Post Date: 2024-09-19
Last Update Post Date Type: ACTUAL